Back to Search
Start Over
Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: A cost-effectiveness analysis.
- Source :
-
JHEP reports : innovation in hepatology [JHEP Rep] 2022 Mar 04; Vol. 4 (5), pp. 100464. Date of Electronic Publication: 2022 Mar 04 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Competing Interests: François Girardin is the representative of Swiss hospitals at the Federal Drug Commission (Federal Office of Public Health) and expert for InnoSuisse - the Federal Agency for Innovation (section Life Sciences). Francesco Negro advises Gilead, Merck and AbbVie, and has received a research grant from Gilead. Lucy Eddowes is an employee of Costello Medical. Please refer to the accompanying ICMJE disclosure forms for further details.
Details
- Language :
- English
- ISSN :
- 2589-5559
- Volume :
- 4
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- JHEP reports : innovation in hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 35368992
- Full Text :
- https://doi.org/10.1016/j.jhepr.2022.100464